Medline ® Abstract for Reference 59
of 'Treatment of chronic myeloid leukemia in chronic phase after failure of initial therapy'
Four-year follow-up of patients with chronic-phase chronic myeloid leukemia (CP-CML) receiving 100 mg of dasatinib once daily
Shah NP, Cortes JE, Schiffer CA, et al
J Clin Oncol. 2010;28(15s):490s.